Topiramate Tablet, Film Coated
Product Images NDC 65862-174

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 65862-174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Kaplan-meier Estimates Of Cumulative Rates For Time To First Seizure (Topiramate Fig1)

The text represents a graph showing cumulative rates for time to the first seizure for two groups, one taking topiramate 50 mg/day (N-234) and the other taking topiramate 400 mg/day (N-236), plotted against time in days up to 500.*

FDA Label Image

Table 12: Efficacy Results In Double-blind, Placebo-controlled, Add-on Epilepsy Trials (Topiramate Fig2)

This appears to be a table with data from a study involving a medication called Topiramate. The table shows groups of participants who were given different doses of the medication or a placebo (shown as "placsbo"). The numbers in the parentheses indicate the total number of participants in each group. The asterisks (*) may be indicating statistically significant results, with the key at the bottom showing that "*p<0.01" and "**p<0.001" indicate different levels of significance. Without access to more context or clearer , it is difficult to provide a full description or interpretation of the data.*

FDA Label Image

Package Label-principal Display Panel (25 mg (60 Tablets Bottle))

These are Topiramate Tablets USP with NDC code 65862-171-60. Each tablet contains 25 mg of Topiramate USP and is manufactured by Aurobindo Pharma USA, Inc. in India. The product information can be found in the accompanying literature, and the Pharmacist should dispense it along with the medication guide. The tablets should be stored in a tight container at room temperature and protected from moisture.*

FDA Label Image

Package Label-principal Display Panel (50 mg (60 Tablets Bottle))

Topiramate is a medication used to treat seizures and prevent migraines. This specific product is manufactured by Aurobindo Pharma USA, Inc. and contains 60 tablets of 50mg each. The medication guide needs to be dispensed separately. The product should be stored in a tight container, protected from moisture, and kept at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Recommended usage should be followed as per the accompanying literature.*

FDA Label Image

Package Label-principal Display Panel (100 mg (60 Tablets Bottle))

This is a description of a medication with the NDC code 65862-173-60 labeled as Topiramate Tablets USP with a strength of 100 mg. It is distributed by Aurobindo Pharma USA, Inc. The medication guide is dispensed separately, and the usual dosage and other relevant prescribing information are included in the literature accompanying the product. It should be stored in a tightly closed container at 20-25°C, with excursions allowed between 15-30°C. The medicine must be safeguarded against moisture.*

FDA Label Image

Package Label-principal Display Panel (200 mg (60 Tablets Bottle))

Topiramate Tablets USP with a strength of 200 mg and a quantity of 60 tablets per bottle. For dose and prescribing information, refer to the accompanying product literature. Distributed by Aurobindo Pharma USA, Inc. The medication guide should be provided separately. Store in a tightly closed container at room temperature and protect from moisture. The code for the product is TS/DRUGS/19/1993. This is for prescription use only.*

FDA Label Image

Chemical Structure (Topiramate Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.